Indication
High Risk Hematological Malignancy
1 clinical trial
1 product
Product
ECT-001-CBClinical trial
A Phase II Open-Label Study of UM171-Expanded Cord Blood Transplantation in Patients With High and Very High Risk Acute Leukemia/MyelodysplasiaStatus: Active (not recruiting), Estimated PCD: 2026-02-01